Survival rates and safety associated with chemoradiotherapy followed by surgery and chemoradiotherapy alone for patients with T4 esophageal cancer: a systematic review and meta-analysis

医学 放化疗 食管癌 子群分析 放射治疗 外科 养生 存活率 内科学 癌症 肿瘤科 置信区间
作者
Chia Ching Lee,Yu Yang Soon,Balamurugan Vellayappan,Francis Ho,Jeremy Tey
出处
期刊:Acta Oncologica [Taylor & Francis]
卷期号:61 (6): 738-748 被引量:4
标识
DOI:10.1080/0284186x.2022.2062680
摘要

Background The optimal treatment approach for T4 esophageal cancer is not well established. We aimed to perform a systematic review and meta-analysis to determine the survival rates and safety of chemoradiotherapy followed by surgery (CRT-S) and chemoradiotherapy alone (CRT) in patients with T4 Nany M0 esophageal cancer.Materials and Methods We searched databases for eligible prospective or retrospective studies. The outcomes of interest were overall survival (OS) at 1, 3 and 5 years, treatment-related fistula formation and mortality rates. Meta-analyses were performed using the random effects models separately for studies evaluating CRT-S and CRT. Subgroup analyses were performed based on histology, radiation dose, chemotherapy regimen and duration of the interval between CRT and surgery.Results We identified 23 studies including 1,119 patients with predominantly squamous cell carcinoma (93%) and adenocarcinoma (3%) histology. The OS rates of patients receiving CRT-S were 65%, 36% and 20% at 1, 3 and 5 years, respectively. The OS rates of patients receiving CRT were 30%, 11% and 10% at 1, 3 and 5 years, respectively. Treatment-related fistula formation rates were 4% for CRT-S and 9% for CRT. Treatment-related mortality rates were 3% for both groups. Subgroup analyses showed that the interval of >2 months between CRT and surgery was associated with significantly improved OS rates at 1, 3 and 5 years.Conclusion Chemoradiotherapy is an efficacious treatment approach for T4 esophageal cancer, with clinically acceptable rates of treatment-related fistula formation and mortality. Tri-modality approach with surgery can be considered in carefully selected patients. Our study findings should be interpreted with caution due to the lack of high-quality evidence. Randomized controlled trials are warranted to confirm these findings.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
1秒前
mg发布了新的文献求助10
2秒前
英姑应助和敬清寂采纳,获得10
2秒前
3秒前
newboy_wxs完成签到,获得积分10
3秒前
3秒前
胡凤至完成签到,获得积分20
3秒前
4秒前
candy发布了新的文献求助10
5秒前
千里发布了新的文献求助10
5秒前
蜂蜜兑多了完成签到,获得积分10
6秒前
6秒前
6秒前
Yvaine发布了新的文献求助30
6秒前
嗯呐发布了新的文献求助10
6秒前
共享精神应助L_93采纳,获得20
7秒前
潮汐发布了新的文献求助10
8秒前
TMOMOR应助科研小猫采纳,获得10
8秒前
dilli发布了新的文献求助10
8秒前
yoga_jiang完成签到,获得积分10
8秒前
Hexagram发布了新的文献求助10
9秒前
沉寂的希望完成签到,获得积分20
9秒前
绿油油完成签到,获得积分10
9秒前
万能图书馆应助胡凤至采纳,获得10
9秒前
10秒前
嘟嘟完成签到,获得积分10
10秒前
11秒前
玛卡巴卡发布了新的文献求助10
11秒前
11秒前
拼搏依玉发布了新的文献求助10
12秒前
潮汐完成签到,获得积分10
13秒前
量子星尘发布了新的文献求助10
13秒前
阿俊1212发布了新的文献求助10
14秒前
14秒前
阿成完成签到,获得积分20
14秒前
一烟尘给一烟尘的求助进行了留言
16秒前
和敬清寂发布了新的文献求助10
17秒前
Ying完成签到 ,获得积分10
18秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Effective Learning and Mental Wellbeing 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976126
求助须知:如何正确求助?哪些是违规求助? 3520340
关于积分的说明 11202586
捐赠科研通 3256847
什么是DOI,文献DOI怎么找? 1798509
邀请新用户注册赠送积分活动 877645
科研通“疑难数据库(出版商)”最低求助积分说明 806516